Vandebriel Rob J, De Jong Wim H
Laboratory for Health Protection Research, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Nanotechnol Sci Appl. 2012 Aug 15;5:61-71. doi: 10.2147/NSA.S23932.
This review summarizes the literature on mammalian toxicity of ZnO nanoparticles (NPs) published between 2009 and 2011. The toxic effects of ZnO NPs are due to the compound's solubility. Whether the increased intracellular [Zn(2+)] is due to the NPs being taken up by cells or to NP dissolution in medium is still unclear. In vivo airway exposure poses an important hazard. Inhalation or instillation of the NPs results in lung inflammation and systemic toxicity. Reactive oxygen species (ROS) generation likely plays an important role in the inflammatory response. The NPs do not, or only to a minimal extent, cross the skin; this also holds for sunburned skin. Intraperitoneal administration induces neurological effects. The NPs show systemic distribution; target organs are liver, spleen, lung, and kidney and, in some cases, the heart. In vitro exposure of BEAS-2B bronchial epithelial cells and A549 alveolar adenocarcinoma cells results in cytotoxicity, increased oxidative stress, increased intracellular [Ca(2+)], decreased mitochondrial membrane potential, and interleukin (IL)-8 production. Decreased contractility of airway smooth muscle cells poses an additional hazard. In contrast to the results for BEAS-2B and A549 cells, in RKO colon carcinoma cells ZnO NPs and not Zn(2+) induce cytotoxicity and mitochondrial dysfunction. Short-term exposure of skin cells results in apoptosis but not in an inflammatory response, while long-term exposure leads to increased ROS generation, decreased mitochondrial activity, and formation of tubular intercellular structures. Macrophages, monocytes, and dendritic cells are affected; exposure results in cytotoxicity, oxidative stress, intracellular Ca(2+) flux, decreased mitochondrial membrane potential, and production of IL-1β and chemokine CXCL9. The NPs are phagocytosed by macrophages and dissolved in lysosomes. In vitro the Comet assay and the cytokinesis-blocked micronucleus assay show genotoxicity, whereas the Ames test does not. This is, however, not confirmed by in vivo genotoxicity assays. Protein binding results in increased stability.
本综述总结了2009年至2011年间发表的关于氧化锌纳米颗粒(NPs)对哺乳动物毒性的文献。氧化锌纳米颗粒的毒性作用归因于该化合物的溶解性。细胞内[Zn(2+)]升高是由于纳米颗粒被细胞摄取还是纳米颗粒在培养基中溶解,目前尚不清楚。体内气道暴露构成重要危害。吸入或滴注纳米颗粒会导致肺部炎症和全身毒性。活性氧(ROS)的产生可能在炎症反应中起重要作用。纳米颗粒不会,或仅在极小程度上穿过皮肤;晒伤皮肤也是如此。腹腔注射会诱发神经学效应。纳米颗粒呈现全身分布;靶器官为肝脏、脾脏、肺和肾脏,在某些情况下还有心脏。体外暴露于BEAS-2B支气管上皮细胞和A549肺泡腺癌细胞会导致细胞毒性、氧化应激增加、细胞内[Ca(2+)]升高、线粒体膜电位降低以及白细胞介素(IL)-8生成。气道平滑肌细胞收缩性降低构成额外危害。与BEAS-2B和A549细胞的结果相反,在RKO结肠癌细胞中,是氧化锌纳米颗粒而非Zn(2+)诱导细胞毒性和线粒体功能障碍。皮肤细胞短期暴露会导致凋亡,但不会引发炎症反应,而长期暴露会导致ROS生成增加、线粒体活性降低以及形成管状细胞间结构。巨噬细胞、单核细胞和树突状细胞会受到影响;暴露会导致细胞毒性、氧化应激、细胞内Ca(2+)通量、线粒体膜电位降低以及IL-1β和趋化因子CXCL9生成。纳米颗粒被巨噬细胞吞噬并在溶酶体中溶解。体外彗星试验和胞质分裂阻滞微核试验显示有遗传毒性,而艾姆斯试验则未显示。然而,体内遗传毒性试验并未证实这一点。蛋白质结合导致稳定性增加。